ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,843Medicare Part D Prescriptions Filled, Including Refills

Rank: 209 out of 780

$635K Total Retail Price of All Prescriptions

Rank: 206 out of 780

620 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 12,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 723 661 1 2
LEVOTHYROXINE SODIUM 477 448 2 5
AMLODIPINE BESYLATE 460 437 3 4
ATORVASTATIN CALCIUM 446 427 4 12
LOSARTAN POTASSIUM 388 344 5 18
FUROSEMIDE 378 368 6 7
POTASSIUM CHLORIDE 367 357 7 11
ZOLPIDEM TARTRATE 349 329 8 17
OMEPRAZOLE 294 256 9 3
WARFARIN SODIUM 288 282 10 24
HYDROCHLOROTHIAZIDE 283 269 11 10
METOPROLOL SUCCINATE 282 282 12 20
CITALOPRAM HBR 237 231 13 23
BISOPROLOL-HYDROCHLOROTHIAZIDE 210 198 14 95
AZITHROMYCIN 205 184 15 38
BENAZEPRIL HCL 196 188 16 59
ATENOLOL 188 159 17 21
HYDROCODONE-ACETAMINOPHEN 175 157 S3 18 1
ALLOPURINOL 160 149 19 29
ALENDRONATE SODIUM 159 155 20 44
METFORMIN HCL 157 151 21 8
MELOXICAM 151 137 22 16
TAMSULOSIN HCL 146 142 23 36
LISINOPRIL 140 133 24 6
NEXIUM 130 130 25 22
LOSARTAN-HYDROCHLOROTHIAZIDE 125 111 26 33
GLIMEPIRIDE 123 105 27 30
AMLODIPINE BESYLATE-BENAZEPRIL 121 114 28 50
METOPROLOL TARTRATE 114 105 29 19
RAMIPRIL 113 103 30 70
TRAMADOL HCL 112 108 31 15
PANTOPRAZOLE SODIUM 111 106 32 25
GABAPENTIN 108 106 33 13
DOXAZOSIN MESYLATE 101 94 34 97
CARVEDILOL 100 98 35 14
CRESTOR 87 84 36 32
CLONIDINE HCL 80 71 37 28
TRIAMTERENE-HCTZ 79 79 38 37
BISOPROLOL FUMARATE 79 72 38 143
PREDNISONE 77 77 40 40
DONEPEZIL HCL 77 72 40 31
PRADAXA 74 74 42 255
SYNTHROID 73 64 43 77
SERTRALINE HCL 72 61 44 27
ESTRADIOL 71 64 R 45 122
LEVOFLOXACIN 68 67 46 76
CYMBALTA 64 58 47 51
TRAZODONE HCL 61 58 48 35
DIOVAN 60 58 49 55
PLAVIX 59 59 50 45
BENICAR 59 59 50 207
SPIRONOLACTONE 58 58 52 53
METFORMIN HCL ER 53 49 53 43
QUINAPRIL HCL 53 53 53 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 40 55 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.